Effective August 8, 2022, the Board of Directors of OncoCyte Corporation appointed Anish John to the position of Chief Financial Officer. Anish John, 52, previously served as Senior Vice President, Finance, and interim Chief Financial Officer since June 2022. Prior to that, Mr. John previously served as Vice President of Operations and Finance, Transplant Business Unit, since September 2021.

He previously served as Senior Director, Financial Planning and Analysis for Foundation Medicine Inc. (“Foundation Medicine”), a wholly owned subsidiary of Roche Holding, AG., from October 2019 to March 2021. Prior to joining Foundation Medicine, Mr. John served in the following various management roles at PerkinElmer Inc.: Senior Director of Finance, Americas Diagnostics from August of 2017 to August of 2019, Director of Finance, Americas Diagnostics from September 2008 to July of 2017, and Senior Manager, Sales Operations and Finance North America from March of 2007 to August of 2008. Mr. John holds an M.B.A. from Babson College, in Wellesley Massachusetts and a B.B. A in Finance from the University of Massachusetts at Amherst.